Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$643M |
| 2 |
AT&T
T
|
+$311M |
| 3 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$306M |
| 4 |
Microsoft
MSFT
|
+$292M |
| 5 |
Ametek
AME
|
+$215M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$887M |
| 2 |
Apple
AAPL
|
+$694M |
| 3 |
PRAH
PRA Health Sciences, Inc.
PRAH
|
+$616M |
| 4 |
Amazon
AMZN
|
+$596M |
| 5 |
Linde
LIN
|
+$531M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.69% |
| 2 | Financials | 6.83% |
| 3 | Healthcare | 6.42% |
| 4 | Industrials | 4.98% |
| 5 | Consumer Discretionary | 4.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1176
American Express
AXP
$227B
| $23M | 0.01% |
137,436
+33,980
| +33% | +$5.68M |
|
1177
Booz Allen Hamilton
BAH
$8.97B
| $23M | 0.01% |
289,689
+50,521
| +21% | +$4.22M |
|
1178
PUT
TransDigm Group
TDG
$65.6B
| $23M | 0.01% |
36,800
+5,500
| +18% | +$3.44M |
|
1179
TransUnion
TRU
$16.3B
| $23M | 0.01% |
204,639
+8,007
| +4% | +$941K |
|
1180
PUT
ARK Innovation ETF
ARKK
$6.6B
| $22.9M | 0.01% |
207,500
-324,400
| -61% | -$39.1M |
|
1181
Norwegian Cruise Line
NCLH
$7.94B
| $22.9M | 0.01% |
858,358
+312,374
| +57% | +$7.95M |
|
1182
Repay Holdings
RPAY
$319M
| $22.9M | 0.01% |
994,681
-349,817
| -26% | -$8.21M |
|
1183
State Street Financial Select Sector SPDR ETF
XLF
$56.7B
| $22.9M | 0.01% |
609,795
-1,031,665
| -63% | -$38.6M |
|
|
ENJY
1184
DELISTED
Enjoy Technology, Inc. Common Stock
ENJY
| $22.9M | 0.01% |
2,289,134
+701,998
| +44% | +$6.96M |
|
1185
CALL
Edwards Lifesciences
EW
$51.9B
| $22.9M | 0.01% |
202,000
-19,500
| -9% | -$2.23M |
|
1186
e.l.f. Beauty
ELF
$6.24B
| $22.8M | 0.01% |
785,899
-7,534
| -0.9% | -$216K |
|
1187
Broadcom
AVGO
$1.7T
| $22.8M | 0.01% |
470,090
+39,230
| +9% | +$1.91M |
|
|
ABMD
1188
CALL
DELISTED
Abiomed Inc
ABMD
| $22.8M | 0.01% |
70,000
+5,000
| +8% | +$1.69M |
|
|
EVRI
1189
DELISTED
Everi Holdings
EVRI
| $22.8M | 0.01% |
941,162
+367,197
| +64% | +$8.39M |
|
1190
SPDR Gold Trust
GLD
$155B
| $22.7M | 0.01% |
138,426
+35,861
| +35% | +$6M |
|
|
MAAC
1191
DELISTED
Montes Archimedes Acquisition Corp. Class A Common Stock
MAAC
| $22.7M | 0.01% |
2,430,346
+901,246
| +59% | +$8.95M |
|
1192
VanEck Oil Services ETF
OIH
$1.94B
| $22.7M | 0.01% |
115,312
+100,108
| +658% | +$19.1M |
|
|
TETC
1193
DELISTED
Tech and Energy Transition Corporation Class A Common Stock
TETC
| $22.7M | 0.01% |
2,323,229
+1,145,100
| +97% | +$11.1M |
|
|
KVSC
1194
DELISTED
Khosla Ventures Acquisition Co. III Class A Common Stock
KVSC
| $22.7M | 0.01% |
2,315,754
-558,094
| -19% | -$5.49M |
|
1195
Freshworks
FRSH
$3.41B
| $22.7M | 0.01% |
+530,736
| New | +$23.8M |
|
1196
United Rentals
URI
$67.5B
| $22.7M | 0.01% |
64,550
-73,644
| -53% | -$24.7M |
|
1197
CALL
Teva Pharmaceuticals
TEVA
$43.9B
| $22.6M | 0.01% |
2,323,600
+2,023,600
| +675% | +$18.9M |
|
1198
GSK
GSK
$104B
| $22.6M | 0.01% |
472,369
-217,334
| -32% | -$10.9M |
|
1199
CareDx
CDNA
$2.54B
| $22.5M | 0.01% |
354,650
-189,512
| -35% | -$14.4M |
|
1200
Entergy
ETR
$49.7B
| $22.5M | 0.01% |
452,604
-2,080,682
| -82% | -$111M |
|
Similar funds
Israel Englander's Q3 2021 Portfolio in Review
As of Q3 2021, Israel Englander held 7,698 positions worth $167B, up 2.3% from $163B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Israel Englander deployed $8.65B of net new capital in Q3 2021, opening 1,245 new positions and adding to 2,719 existing holdings. Its largest new stake was Sight Sciences: 1,577,092 shares worth $35.8M.
By sector, the portfolio is most concentrated in Technology at 7.7% of assets, down from 8.2% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Apple, an estimated $694M trimmed.
- Israel Englander's largest Q3 2021 buy was Sight Sciences: 1,577,092 shares worth $35.8M.
- Israel Englander added most to State Street SPDR S&P 500 ETF Trust in Q3 2021, an estimated $643M increase.
- Israel Englander's biggest Q3 2021 reduction was Apple, cutting an estimated $694M.
- Israel Englander fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $887M.
- Israel Englander's ten largest holdings make up 18% of its $167B portfolio in Q3 2021.
- Israel Englander opened 1,245 new positions and closed 981 in Q3 2021.
- Israel Englander's portfolio value rose 2.3% quarter-over-quarter to $167B.
Based on Millennium Management's 13F filing for Q3 2021, filed 15 Nov 2021.